Understanding the genetic architecture of amyotrophic lateral sclerosis in Thais

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220121007

Enrollment

Registered

2022-01-21

Start date

2022-01-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic lateral sclerosis patients in category of possible, probable and definite ALS at any stage of disease defined by El Escorial criteria. Amyotrophic lateral sclerosis Genetic study Whole genome sequencing

Interventions

Amyotrophic lateral sclerosis patients in category of possible, probable and definite ALS at any stage of disease defined by El Escorial criteria.

Basic Science

Amyotrophic lateral sclerosis patients

Eligibility

Sex/Gender

All

Age

20 Years to No maximum

Inclusion criteria

Inclusion criteria: Amyotrophic lateral sclerosis patients in category of possible, probable and definite ALS at any stage of disease defined by El Escorial criteria.

Exclusion criteria

Exclusion criteria: Other types of motor neuron disease or other causes of weakness

Design outcomes

Primary

Measure	Time frame
Whole genome sequencing Last follow up at 5 years Whole genome sequencing	—

Secondary

Measure	Time frame
Inflammatory status Last follow up at 5 years Inflammatory marker	—

Countries

Thailand

Contacts

Public ContactChayasak Wantaneeyawong

Chiang Mai University

chayasak77@gmail.com053935899

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026